In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden. [electronic resource]
Producer: 20140204Description: 966-71 p. digitalISSN:- 1476-5365
- Adolescent
- Adult
- Aged
- Autografts
- Female
- Fibroblast Growth Factor 7 -- administration & dosage
- Follow-Up Studies
- Humans
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- epidemiology
- Myeloablative Agonists
- Stem Cell Transplantation
- Stomatitis -- epidemiology
- Transplantation Conditioning
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.